Page
%P
-
Article
Open AccessPROX1 is a predictor of survival for gliomas WHO grade II
The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers ...